# Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients

> **NCT05502081** · PHASE4 · COMPLETED · sponsor: **Mansoura University Hospital** · enrollment: 265 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Casirivimab and Imdevimab Drug Combination
- **DRUG:** Remdesivir
- **DRUG:** Favipiravir

## Key facts

- **NCT ID:** NCT05502081
- **Lead sponsor:** Mansoura University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-02
- **Primary completion:** 2022-12-28
- **Final completion:** 2022-12-28
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2023-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05502081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05502081, "Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05502081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*